Does EPCORITAMAB Cause Diffuse large b-cell lymphoma? 86 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Diffuse large b-cell lymphoma have been filed in association with EPCORITAMAB (EPKINLY). This represents 4.2% of all adverse event reports for EPCORITAMAB.
86
Reports of Diffuse large b-cell lymphoma with EPCORITAMAB
4.2%
of all EPCORITAMAB reports
46
Deaths
15
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From EPCORITAMAB?
Of the 86 reports, 46 (53.5%) resulted in death, 15 (17.4%) required hospitalization.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPCORITAMAB. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does EPCORITAMAB Cause?
Cytokine release syndrome (551)
Pyrexia (258)
Off label use (229)
Febrile neutropenia (219)
Pneumonia (154)
Covid-19 (125)
Sepsis (106)
Hypotension (95)
Neutropenia (84)
Diarrhoea (83)
What Other Drugs Cause Diffuse large b-cell lymphoma?
RITUXIMAB (1,571)
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
Which EPCORITAMAB Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
EPCORITAMAB vs EPCORITAMAB-BYSP
EPCORITAMAB vs EPERISONE
EPCORITAMAB vs EPHEDRINE
EPCORITAMAB vs EPINASTINE
EPCORITAMAB vs EPINEPHRINE